Development of Novel Monoclonal Antibodies for Evaluation of Transmembrane Prostate Androgen-Induced Protein 1 (TMEPAI) Expression Patterns in Gastric Cancer-Reference-Cited by-同舟云学术

Development of Novel Monoclonal Antibodies for Evaluation of Transmembrane Prostate Androgen-Induced Protein 1 (TMEPAI) Expression Patterns in Gastric Cancer

Published:2017-06-05 Issue:2 Volume:24 Page:427-438
ISSN:1219-4956
Container-title:Pathology & Oncology Research
language:en
Short-container-title:Pathol. Oncol. Res.

Author:

Karbyshev Mikhail S.,Grigoryeva Evgeniya S.,Volkomorov Viktor V.,Kremmer Elisabeth,Huber Alexander,Mitrofanova Irina V.,Kaigorodova Evgeniya V.,Zavyalova Marina V.,Kzhyshkowska Julia G.,Cherdyntseva Nadezda V.,Choynzonov Evgeny L.

Funder

Russian Fund for Basic Research

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine,Pathology and Forensic Medicine

Link

http://link.springer.com/article/10.1007/s12253-017-0247-x/fulltext.html

Reference47 articles.

1. Stone L (2015) Prostate cancer: TGF-beta signalling regulator PMEPA1 halts metastases tobone. Nat Rev Urol 12(7):362

2. Xu LL et al (2000) A novel androgen-regulated gene, PMEPA1, located on chromosome20q13 exhibits high level expression in prostate. Genomics 66(3):257–263

3. Watanabe Y et al (2010) TMEPAI, a transmembrane TGF-beta-inducible protein, sequestersSmad proteins from active participation in TGF-beta signaling. Mol Cell 37(1):123–134